Stay updated with breaking news from Nasdaq mrns. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.68) per share for the quarter. Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) last issued its earnings results on Tuesday, March 5th. The […] ....
Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) will be posting its quarterly earnings results before the market opens on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.68) per share for the quarter. Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) last released its quarterly earnings data on Tuesday, March 5th. The biopharmaceutical […] ....
Mach 1 Financial Group LLC reduced its stake in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report) by 35.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 43,828 shares of the biopharmaceutical company’s stock after selling 24,375 shares during the period. […] ....
Mach 1 Financial Group LLC lessened its stake in shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report) by 35.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 43,828 shares of the biopharmaceutical company’s stock after selling 24,375 shares during the period. Mach 1 […] ....
Robert W. Baird restated their neutral rating on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a research note issued to investors on Tuesday, Marketbeat Ratings reports. A number of other equities research analysts have also recently commented on MRNS. Royal Bank of Canada reissued a sector perform rating and issued a $3.00 price […] ....